Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 539

Results For "ACC"

5458 News Found

PerkinElmer to donate 1 million rapid COVID-19 antigen test kits in India
News | May 07, 2021

PerkinElmer to donate 1 million rapid COVID-19 antigen test kits in India

Much-needed diagnostics supplies will help accelerate testing capabilities of hospitals and clinics across India


Roche receives emergency use authorisation of COVID-19 drug
News | May 07, 2021

Roche receives emergency use authorisation of COVID-19 drug

This Emergency Use Authorisation will now enable Roche to import the globally manufactured product batches to India


Lonza announces expansion plans for mammalian manufacturing facilities
News | May 07, 2021

Lonza announces expansion plans for mammalian manufacturing facilities

The facility is expected to be completed in 2024


Alembic announces USFDA approval for two drugs
News | May 06, 2021

Alembic announces USFDA approval for two drugs

Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, 2% and 0.5% has an estimated market size of US $80 million for twelve months ending December 2020 according to IQVIA


Glenmark launches Ryaltris-AZ at affordable price
News | May 04, 2021

Glenmark launches Ryaltris-AZ at affordable price

First company in the world to launch Ryaltris-AZ, as a novel fixed dose combination of Mometasone furoate 50 mcg + Azelastine 140 mcg


Biosimilars performance below expectations for Biocon : ICICI Direct
Biotech | May 03, 2021

Biosimilars performance below expectations for Biocon : ICICI Direct

The progress has been encouraging with approvals and launches in the US, EU, Japan, Australia and Emerging Markets. Post Mylan Upjohn (Pfizer) merger, the scope has been extended to China as well.


Dr. Reddy's launches Albendazole tablets in US
News | April 30, 2021

Dr. Reddy's launches Albendazole tablets in US

Dr. Reddy’s Albendazole Tablets, USP are available in 200 mg tablets in bottle count sizes of two


Cipla signs agreement with Merck for Molnupiravir
News | April 29, 2021

Cipla signs agreement with Merck for Molnupiravir

Molnupiravir is an investigational oral antiviral drug currently being studied in a Phase 3 trial for the treatment of non-hospitalized patients with confirmed COVID-19


Biocon and Viatris receive EC approval for Biosimilar Bevacizumab
Biotech | April 28, 2021

Biocon and Viatris receive EC approval for Biosimilar Bevacizumab

The drug is approved for the treatment in metastatic colorectal carcinoma, metastatic breast cancer and ovarian, cervical and renal cancer


Govt. waives off basic customs duty & health cess on oxygen equipment
News | April 26, 2021

Govt. waives off basic customs duty & health cess on oxygen equipment

Apart from the above, it was also decided that Basic Customs Duty on import of COVID-19 vaccines be also exempted with immediate effect for a period of 3 months